UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The extracellular domain of Her2 in serum as a biomarker of breast cancer

Laboratory investigation, 2018-06, Vol.98 (6), p.696-707

2018

Volltextzugriff (PDF)

Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update

International journal of molecular sciences, 2021-06, Vol.22 (12), p.6587

2021

Volltextzugriff (PDF)

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

Journal of translational medicine, 2010-07, Vol.8 (1), p.71-71, Article 71

2010

Volltextzugriff (PDF)

Preclinical Pharmacology of the Taxanes: Implications of the Differences

The oncologist (Dayton, Ohio), 2004-06, Vol.9 (S2), p.3-8

2004

Volltextzugriff (PDF)

An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies

PloS one, 2020-01, Vol.15 (1), p.e0227356-e0227356

2020

Volltextzugriff (PDF)

Association between overweight, obesity, and quality of life of patients receiving an anticancer treatment for prostate cancer: a systematic literature review

Health and quality of life outcomes, 2023-01, Vol.21 (1), p.11-11, Article 11

2023

Volltextzugriff (PDF)

Interaction between Radiation Therapy and Targeted Therapies in HER2-Positive Breast Cancer: Literature Review, Levels of Evidence for Safety and Recommendations for Optimal Treatment Sequence

Cancers, 2023-04, Vol.15 (8), p.2278

2023

Volltextzugriff (PDF)

Local and Regional Breast Cancer Recurrences: Salvage Therapy Options in the New Era of Molecular Subtypes

Frontiers in oncology, 2018-04, Vol.8, p.112-112

2018

Volltextzugriff (PDF)

Pertuzumab and trastuzumab: the rationale way to synergy

Anais da Academia Brasileira de Ciências, 2016-01, Vol.88 Suppl 1 (suppl 1), p.565-577

2016

Volltextzugriff (PDF)

Influence of chemotherapy on postural control and quality of life in women with gynaecological cancer: a protocol of a prospective observational study

BMJ open, 2022-09, Vol.12 (9), p.e061664

2022

Volltextzugriff (PDF)

Breast Cancer Management during the COVID 19 Pandemic: French Guidelines

European journal of breast health, 2020-07, Vol.16 (3), p.160-161

2020

Volltextzugriff (PDF)

Systemic therapy for early-stage breast cancer: learning from the past to build the future

Nature reviews. Clinical oncology, 2022-12, Vol.19 (12), p.763-774

2022

Volltextzugriff (PDF)

Percutaneous Image-Guided Electrochemotherapy of Spine Metastases: Initial Experience

Cardiovascular and interventional radiology, 2019-12, Vol.42 (12), p.1806-1809

2019

Volltextzugriff (PDF)

Feasibility, criterion and construct convergent validity of the 2-minute walk test and the 10-meter walk test in an oncological context

Heliyon, 2023-11, Vol.9 (11), p.e22180-e22180, Article e22180

2023

Volltextzugriff (PDF)

Citrate targets FBPase and constitutes an emerging novel approach for cancer therapy

Cancer cell international, 2018-11, Vol.18 (1), p.175-175, Article 175

2018

Volltextzugriff (PDF)

Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort Study

Cancers, 2021-09, Vol.13 (19), p.4749

2021

Volltextzugriff (PDF)

Impact of the COVID‐19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study

Cancer medicine (Malden, MA), 2023-11, Vol.12 (22), p.20918-20929

2023

Volltextzugriff (PDF)

Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2–Overexpressing Stage II or III Breast Cancer: Results of the GETN(A)-1 Trial

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2678-2684

2007

Volltextzugriff (PDF)

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study

The oncologist (Dayton, Ohio), 2017-10, Vol.22 (10), p.1222-1231

2017

Volltextzugriff (PDF)

The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review

Sovremennaia onkologiia : zhurnal kafedry onkologii RMAPO dlia nepreryvnogo poslediplomnogo obrazovaniia, 2021-02, Vol.22 (4), p.47-55

2021

Volltextzugriff (PDF)

Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial

Cancers, 2020-11, Vol.12 (12), p.3509

2020

Volltextzugriff (PDF)

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion

ESMO open, 2019, Vol.4 (6), p.e000565-e000565, Article e000565

2019

Volltextzugriff (PDF)

Weekly paclitaxel—still preferred first-line taxane for mBC

Nature reviews. Clinical oncology, 2015-09, Vol.12 (9), p.508-509

2015

Volltextzugriff (PDF)

Breast cancer: weekly paclitaxel--still preferred first-line taxane for mBC

Nature reviews. Clinical oncology, 2015-09, Vol.12 (9), p.508-509

2015

Volltextzugriff (PDF)

1 – 25 von 245

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(224)
Mit Volltextzugriff
(189)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(115)
Life Sciences & Biomedicine
(111)
Humans
(97)
Oncology
(91)
Female
(73)
Breast Cancer
(56)
Breast Neoplasms - Drug Therapy
(41)
Cancer
(39)
Life Sciences
(37)
Breast Neoplasms - Pathology
(32)
Chemotherapy
(30)
Middle Aged
(30)
Adult
(29)
Aged
(28)
Tumors
(26)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Prognosis
(23)
Trastuzumab
(21)
Antineoplastic Agents - Therapeutic Use
(18)
Male
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Bulletin Du Cancer
(59)
Journal Of Clinical Oncology
(25)
Cancer Research
(18)
Oncologie
(13)
Cancer
(8)
The Journal Of High Energy Physics
(8)
The Oncologist
(8)
The oncologist
(7)
Breast Cancer Research And Treatment
(6)
Cancers
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The extracellular domain of Her2 in serum as a biomarker of breast cancer

Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

Preclinical Pharmacology of the Taxanes: Implications of the Differences

An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies

Association between overweight, obesity, and quality of life of patients receiving an anticancer treatment for prostate cancer: a systematic literature review

Interaction between Radiation Therapy and Targeted Therapies in HER2-Positive Breast Cancer: Literature Review, Levels of Evidence for Safety and Recommendations for Optimal Treatment Sequence

Local and Regional Breast Cancer Recurrences: Salvage Therapy Options in the New Era of Molecular Subtypes

Pertuzumab and trastuzumab: the rationale way to synergy

Influence of chemotherapy on postural control and quality of life in women with gynaecological cancer: a protocol of a prospective observational study

Breast Cancer Management during the COVID 19 Pandemic: French Guidelines

Systemic therapy for early-stage breast cancer: learning from the past to build the future

Percutaneous Image-Guided Electrochemotherapy of Spine Metastases: Initial Experience

Feasibility, criterion and construct convergent validity of the 2-minute walk test and the 10-meter walk test in an oncological context

Citrate targets FBPase and constitutes an emerging novel approach for cancer therapy

Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort Study

Impact of the COVID‐19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study

Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2–Overexpressing Stage II or III Breast Cancer: Results of the GETN(A)-1 Trial

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study

Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer

The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review

Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion

Weekly paclitaxel—still preferred first-line taxane for mBC

Breast cancer: weekly paclitaxel--still preferred first-line taxane for mBC

Aktive Filter

Suchergebnisse filtern